Surviving crises
as filed5.5/10
Has it survived what it has been through?
1 warning event since 2022; the latest 2025-01-31.
weight 33% of this tense · 55th percentile among 121 sector filers · read for itself
From the record
WORK Medical Technology Group LTD's filings since 2022 show 1 warning event: a late-report notice (Form NT 10-K or NT 10-Q, the latest 2025-01-31) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Track record
as filed2.4/10
What has it actually done, year after year?
-20.6% a year over 4 filed years; profitable in 2 of 4.
weight 45% of this tense · 24th percentile among 105 sector filers · read for its customers
From the record
WORK Medical Technology Group LTD's 4 filed years say what it did: revenue went from $20 million in fiscal 2022 to $10 million in fiscal 2025, down 20.6% a year; it rose in 0 of 3 years; the deepest fall was 50% from fiscal 2022 to fiscal 2025; net income was positive in 2 of 4 of those years (its annual reports).
What it rests on
- revenue growth over the filed span-20.6%bottom 6% of its family
- the share of years revenue rosebottom 2% of its family
- the share of filed years with a profittop 30% of its family
- the deepest fall from a revenue peak50.0%bottom 18% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Shareholder treatment
as filed2.3/10
How has it treated the people who own it?
Share count grew 32.3% a year. 0% of cash flow returned. Insiders: 0 sales, 0 purchases.
weight 22% of this tense · 23rd percentile among 40 sector filers · read for its shareholders
From the record
Over the 3 fiscal years to 2025-09-30, WORK Medical Technology Group LTD's diluted share count grew about 32.3% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).
What it rests on
- the share count over the yearsbottom 32% of its family
- cash returned against operating cash flowbottom 13% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.